Table I Index
Table of Contents
Table I - 67 Putnam Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 150 | 400.6 | 74 | 429.7 | 76 | 383.7 |
Oral cavity and pharynx | * | # | * | # | * | # |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 25 | 62.5 | 10 | 57.4** | 15 | 63.7** |
Esophagus | * | # | * | # | * | # |
Stomach | * | # | * | # | * | # |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 14 | 34.1** | 5 | 27.7** | 9 | 39.4** |
Rectum and rectosigmoid | 6 | 14.5** | * | # | * | # |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | * | # | * | # | * | # |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 33 | 89.5 | 21 | 121.3 | 12 | 68.7** |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | * | # | * | # | * | # |
Lung and bronchus | 29 | 79.8 | 18 | 104.2** | 11 | 62.9** |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | * | # | * | # | * | # |
Skin (excluding basal and squamous) | 10 | 27.0** | 6 | 31.6** | * | # |
Melanoma of the skin | 9 | 24.7** | 5 | 27.4** | * | # |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 25 | 67.5 | * | # | 24 | 128.2 |
Female genital system | 8 | 20.9** | -- | -- | 8 | 39.8** |
Cervix uteri | * | # | -- | -- | * | # |
Corpus uteri | 5 | 14.4** | -- | -- | 5 | 28.4** |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | * | # | -- | -- | * | # |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 14 | 36.0** | 14 | 79.7** | -- | -- |
Prostate gland | 11 | 27.5** | 11 | 64.0** | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 14 | 35.7** | 8 | 46.7** | 6 | 24.5** |
Urinary bladder | 10 | 24.8** | 6 | 35.0** | * | # |
Kidney and renal pelvis | * | # | * | # | * | # |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | * | # | * | # | * | # |
Brain | * | # | * | # | * | # |
Other nervous system | * | # | * | # | * | # |
Endocrine system | * | # | * | # | * | # |
Thyroid gland | * | # | * | # | * | # |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 9 | 26.3** | 7 | 42.3** | * | # |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | 5 | 11.9** | * | # | * | # |
Multiple myeloma | * | # | * | # | * | # |
Leukemia | * | # | * | # | * | # |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | * | # | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | * | # | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |